INHEART RAISES $11M TO ACCELERATE DEVELOPMENT & DEPLOYMENT OF NOVEL THERAPEUTIC, PREDICTIVE, AND SCREENING CARDIAC SOLUTIONS
CAMBRIDGE, Mass. and BORDEAUX, France, May 6, 2024 /PRNewswire/ -- inHEART, a medical device company delivering the world's most advanced, AI-driven digital twin of the heart, has raised $11M to drive commercial growth of its therapeutic software solution for cardiac ablation procedures and advance the development of its predictive cardiac models for heart failure, sudden cardiac death, and cardio-embolic stroke.
- In addition, inHEART received funds from a successful crowdequity campaign on Tudigo and from the UK impact fund Astorg Foundation.
- "We welcome this strong international group of investors to our latest round of financing," said Todor Jeliaskov, Chairman and CEO of inHEART.
- "This new round allows us to go further in addressing the needs of cardiac patients from early screening and disease detection through advanced therapeutic support.
- The inHEART solution creates highly detailed, interactive 3D heart models with proprietary AI-driven cardiac CT or MR image segmentation.